1. A prospective cohort study to identify and evaluate endotypes of venous thromboembolism: Rationale and design of the Genotyping and Molecular Phenotyping in Venous ThromboEmbolism project (GMP-VTE). Issue 181 (September 2019) Authors: Ten Cate, V.; Koeck, T.; Panova-Noeva, M.; Rapp, S.; Prochaska, J.H.; Lenz, M.; Schulz, A.; Eggebrecht, L.; Hermanns, M.I.; Heitmeier, S.; Krahn, T.; Laux, V.; Münzel, T.; Leineweber, K.; Konstantinides, S.V.; Wild, P.S. Journal: Thrombosis research Issue: Issue 181(2019) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor‐induced hypercoagulability in vitro and in vivo. (19th June 2014) Authors: Perzborn, E.; Heitmeier, S.; Buetehorn, U.; Laux, V. Journal: Journal of thrombosis and haemostasis Issue: Volume 12:Number 7(2014:Jul.) Page Start: 1054 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dissociation between the pharmacokinetics and pharmacodynamics of once‐daily rivaroxaban and twice‐daily apixaban: a randomized crossover study. (14th September 2017) Authors: Kreutz, R.; Persson, P. B.; Kubitza, D.; Thelen, K.; Heitmeier, S.; Schwers, S.; Becka, M.; Hemmrich, M. Journal: Journal of thrombosis and haemostasis Issue: Volume 15:Number 10(2017) Page Start: 2017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-09 Proteomic profiling in cancer-associated VTE. Issue 200 (April 2021) Authors: Panova-Noeva, M.; Schulz, A.; Köck, T.; ten Cate, V.; Wagner, B.; Rapp, S.; Lenz, M.; Zink, A.; Ghadessi, M.; Konstantinides, S.; ten Cate, H.; Heitmeier, S.; Wild, P. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗